Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab.

Source:http://linkedlifedata.com/resource/pubmed/id/17082014

Download in:

View as

General Info

PMID
17082014